AUDUSD SELL• breakout could happen anytime now, market has converged at the apex and it has lot momentum
• looking for it to sell based on my analysis of DXY and my target area is that previous significant trough
BLUE
USDCHF BUY • on the D1 timeframe the market has formed a downward and upward trendline
• market has respected the upward trendline and a bullish engulfing candlestick has formed so i'll be looking for market to go test the downward trendline again in the next coming days
• as market converges by the apex i'll be looking for a breakout but now i'm looking for LONG TRADES
• on the H4 an inner downward trendline was formed so once market breaks it i'll go LONG and targets will be by the downward trendline
NZDUSD BUYreasons for a potential buy/breakout are
• my current DXY analysis signals a long term sell so basically a long term buy on this pair
• expecting market to go retest a previous broken resistance new found support before continuing in this bullish move due to the spinning top on the H4
AUDUSD BUY• market broke out of the downward trendline, so we looking for BUYS
• a doji formed on the D1 so loss of momentum i'll then be looking for market to reach my upward trendline where i'll place my buys
• or market could be retesting the broken trendline which is still a buy trade w more pips :)
• if market violates that trendline then i'll enter a sell but i'm still strong on a bullish movement on this pair
1 Corinthians 3:6this is a +$5.3 trillion market and there's only about 10 million of us traders in the markets, we're all millionaires we just have to keep pushing and sowing our seeds and wait for God to make all those tears, headaches, deposits, late nights and sacrifices grow in something we have not even imagined. now let's get to looking at the charts couple of ideas to follow oh and don't forget to look at the chart above :)
AUDUSD ANALYSIS analysis self explanatory i may say feel free to comment if you do not understand :)
GBPJPY ANALYSIS on friday market broke a significant bearish trendline both because of technicals (market was bullish for about two weeks) and fundamentals (nfp) so i'll be looking for market to lose a bit of momentum next week which will result in a retest (corrective move) before continuing in it's bullish move my predictions say that market will reach my tp area
YEN BASKET ANALYSIS FOR NEXT WEEKon friday market tanked down because of of nfp and also because of technicals (market was already bearish for 2 weeks) so upcoming week there'll be a slow of momentum resulting in a corrective move (retest of broken trendline) then market will continue in overall direction and i'll be looking for price to reach my take profit level as it was a support level in the past
Bluebird Bio Inc 🧙bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
Here you can see pipeline:
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-212 Northstar-3 Phase 3 updated at EHA June 11, 2021. 89% (32/36) of evaluable patients achieved transfusion independence (TI) and remain transfusion free (HGB-207, HGB-212)
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-207 Northstar-2 Phase 3 updated at EHA June 11, 2021. 89% (32/36) of evaluable patients achieved transfusion independence (TI) and remain transfusion free (HGB-207, HGB-212)
Lenti-D (Elivaldogene Autotemcel / Eli-Cel) - ALD-102 Phase 2/3 updated data presented March 15, 2021. 90% of evaluable patients (27/30) alive and free of major functional disabilities at two years follow-up.
Betibeglogene autotemcel (beti-cel) (LentiGlobin) BLA filing to be completed
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-206 Phase 1/2 trial temporarily suspended due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML) - February 16, 2021. Clinical hold lifted June 7, 2021. Data to be presented by end of 2021.
Lenti-D (Elivaldogene Autotemcel / Eli-Cel) - ALD-104 Phase 3 safety data to be presented at EBMT 2020. Noted two adverse events (out of 13 patients) of pancytopenia were considered possibly related to Lenti-D. Phase 3 trial placed on clinical hold - noted August 9, 2021. BLA filing due 2021 subject to resolution of the clinical hold.
ABECMA (idecabtagene vicleucel) Phase 1 data presented at ASH 2020.
bb21217 (CRB-402) Phase 1 data due by end of 2021.
MGTA-145 and plerixafor Phase 2 trial to be initiated 4Q 2021.
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - (HGB-210) Phase 3 trial temporarily suspended due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML) - February 16, 2021. Clinical hold lifted June 7, 2021.
ADA $32 possible price target 2021 pick your colorpick your pill; yellow or blue? Which pattern are we possibly taking for a possible $32 end of bull run 2021 for ADA? Comment below.
Space RaceSome companies involve in the space race as of mid 2021. Perhaps precedent setting for future entries by Starlink, SpaceX, Blue Moon, Telesat, OneWeb
On display are: ARKX, GSAT, SPCE, LORL and ASTR
NASDAQ 100 STILL SHORTTech stocks have been getting hammered and i still believe the stock market is headed for a big correction. Smart investors are seeing more gains in crypto-currency. We are not seeing anymore stimulus packages thus far and inflation is getting higher month by month. Bond Yields are all on an uptrend. That's a negative correlation with high growth stocks. Looking for a big correction then i could long from there. If we crash guess we all will be rich if you know how to short the market.I did buy the dip thursday but I'm still in my swing sells from (14000-14100) range. Comments and like please. thanks.
USDJPY4H technical All Strong BuyUSDJPY4H is trending bullish, price is above ema .sto rsi indicator is going up.Technical All Strong Buy
if you find this analysis useful, please support me with your likes and comments.
If you have another analysis on this pair, please share it in the comments.
Good luck
BLUE - Long Setup FA Looking for Break above $31.07 Stop Signal: $27.97 Target1 : 38.43 Target 2: Momentum. Negligible insider activity.
HCICU could turn around from hereHCICU could turn around from here.
Was that the bottom ?
Did someone just fat figure buy the bottom as a signal?
BLUE Technical Analysis 🧙Bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
PowerPool might retest the trend line lower - buy opportunity!Blue DeFi chips will fly and smash all resistances, but keep an eye on this as we might get rejected, if so you can buy lower.
BLUE - Good Buying Opportunity With 3.42B Market Cap Bluebird Bio after four years again on good level to Buy, Profit Target Primary 70-80 and secondary is 100-140.
You can take this stock from short term to long term.
Swing Trade: BLUE in Breakout modeHi guys,
Sharing one of my today swingtrades in healtcare on BLUE.
Nice setup for breakout.
If you like the idea, do not forget to support with a 👍 like and follow.
Leave a comment that is helpful or encouraging. Let's master the markets together.
